Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is -17.18% vs -37.54% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -94.25% vs -39.81% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -56.96% vs -55.83% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is -83.33% vs 114.29% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of Walvax Biotechnology Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 49.57% vs -32.04% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -17.18% vs -37.54% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 163.96% vs 88.82% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -94.25% vs -39.81% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 52.15% vs 151.40% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -56.96% vs -55.83% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 25.00% vs -50.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -83.33% vs 114.29% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






